| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 62 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 62 |
| 2 | FUROSEMIDE | 37 |
| 3 | OXALIPLATIN | 20 |
| 4 | RAMIPRIL | 20 |
| 5 | BEVACIZUMAB | 17 |
| 6 | AMLODIPINE | 16 |
| 7 | METHOTREXATE SODIUM | 16 |
| 8 | FLUOROURACIL | 15 |
| 9 | FLUOROURACIL CREAM, 0.5% | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 1 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 2 | DELAFLOXACIN MEGLUMINE | 1 | 0.0041 |
| 3 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2 | 0.0041 |
| 4 | HYALURONIC ACID | 3 | 0.0026 |
| 5 | ROLAPITANT | 1 | 0.0019 |
| 6 | SELEGILINE HYDROCHLORIDE | 1 | 0.0017 |
| 7 | TEBENTAFUSP | 1 | 0.0017 |
| 8 | CEMIPLIMAB-RWLC | 3 | 0.0014 |
| 9 | LETERMOVIR | 4 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 2 | Nuclear Export Inhibitor [EPC] | 9 | 0.0010 |
| 3 | Methylating Agent [EPC] | 1 | 0.0010 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 6 | Lipopeptide Antibacterial [EPC] | 4 | 0.0004 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 9 | 0.0002 |